Clinical Trial Technology Editorial

  1. Executives Are Eager — But Concerned — For The Future Of AI In Clinical Trials 12/14/2022

    Most life sciences execs agree that their companies — even early adopters of AI — still need to make significant changes to leverage AI properly. Here's how to get started (or keep forging ahead).

  2. Boehringer Ingelheim Implements One Medicine Technology Platform 12/8/2022

    For years, Boehringer Ingelheim operated with a system comprised of best-of-breed solutions from different vendor companies. After carefully evaluating the technology environment, the company decided to move from best-of-breed solutions to an end-to-end product development platform.

  3. What Astellas Has Learned About Decentralized Trials 11/28/2022

    When the COVID pandemic hit in the spring of 2020, many companies were unprepared for the changes that were about to impact their studies. Astellas is one company that was better prepared than most. The company had initiated a formalized, internal project on decentralized clinical trial (DCT) technologies and their use in clinical trials about nine months prior to the pandemic.

  4. Trusting Digital Health Technologies: Why Global Standards Are A Must 11/22/2022

    The clinical trials industry is compelled to embrace digital transformation in its approach to patient recruitment and engagement, study design protocols, and overall trial management. But what's the crucial component to ensure its success? Global standards that help cultivate trust.

  5. Needed: An AI Revolution In The Rare Disease Space 11/11/2022

    Quris has developed a treatment for Fragile-X Syndrome, the most common inherited cause of autism and intellectual disabilities worldwide. Isaac Bentwich M.D., the founder and CEO of Quris, believes the rare disease space, in general, is a difficult one to navigate.

  6. Top Site Complaints: Budgets, Communication, And Technology 9/27/2022

    Technology firm Greenphire conducts an annual survey to determine the trending issues that matter most to clinical sites. Last year the company asked me if there was a question that I would like to see included in their survey. I requested that Greenphire ask its survey takers about the one thing they would like sponsor companies to do for them. The sites responded.

  7. Digital Solutions, Technology, And Patient Care Top Life Science Trends 9/6/2022

    Technology company Within3 has produced a paper on the six top trends that are going to impact the pharmaceutical space. It’s no surprise that technology solutions were one of the trends making the list, but also included were factors such as patients, cyber threats, and a growing global marketplace.

  8. How Is The Role Of Clinical Data Manager Changing? 8/30/2022

    The results of a study are only as good as the data collected. For that reason, clinical data managers (CDMs) are often the unsung heroes of clinical trials. Those managers must ensure the collected data is accurate, while avoiding tainted data that can endanger patients, studies, and the reputations of the companies conducting the research.

  9. How To Operationalize Diversity In Clinical Trials 5/31/2022

    Changes are quickly taking place regarding the push for patient diversity in clinical trials. For years, sponsor companies have been trying to increase the number of ethnic and diverse patients in their studies. Soon, they will face tougher oversight. Here is how one company is overcoming the challenge.

  10. New Clinical Studies In ALS Show Promise 5/24/2022

    Right now, there is no cure for amyotrophic lateral sclerosis (ALS) and approved therapies only moderately slow progression of the disease. However, new clinical studies are taking new approaches to targeted therapy, including using a platform trial design, investigating secondary endpoints, and using brain-computer interfaces.